Histone cluster 1 H4F activators would comprise a class of biochemical agents designed to selectively target and modulate the activity of the H4F variant of histone H4, one of the core components of the nucleosome. Histone H4 is integral to the formation and function of the nucleosome, which consists of a segment of DNA wrapped around an octamer of histone proteins, including two each of H2A, H2B, H3, and H4. Histone variants like H4F can carry specific and unique post-translational modifications or sequence divergences that imbue them with distinctive properties influencing nucleosome assembly, stability, and the interaction with chromatin remodeling complexes. These subtle variations can affect the higher-order structure of chromatin and subsequently the regulation of genomic regions. Activators that specifically interact with the H4F variant would aim to bind to and alter the function of this histone, thereby modulating the structure and dynamics of chromatin in a precise manner. The binding of these activators to H4F could lead to changes in the nucleosomal landscape, potentially affecting the compactness of chromatin and the accessibility of DNA to various nuclear factors.
To investigate and develop H4F activators, a thorough molecular understanding of the H4F histone variant is required. This involves identifying the unique sites within H4F that could serve as potential targets for activator binding, thereby ensuring the specificity of the interaction. Such specificity is crucial to avoid off-target effects on other histone proteins and maintain nucleosomal integrity. Structural analysis using advanced techniques like X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy would be pivotal in revealing the three-dimensional arrangement of H4F within the nucleosome. This knowledge would guide the design of molecules capable of precisely engaging with the H4F variant. Furthermore, functional assays would be crucial to test the binding efficacy of these activators to H4F and to elucidate their impact on nucleosome dynamics. These could include monitoring changes in nucleosome remodeling, assessing the kinetics of nucleosome assembly and disassembly, and investigating the influence of H4F activators on the physical properties of chromatin fibers. Through these scientific explorations, the role of histone variants like H4F in chromatin architecture and the potential for selective modulation of chromatin structure could be better understood.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is an HDAC inhibitor which may increase histone acetylation, potentially enhancing gene expression including histones. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is known to inhibit HDACs, which can lead to hyperacetylation of histones, potentially inducing their expression. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat selectively inhibits class I HDACs, possibly affecting chromatin structure and increasing histone gene expression. | ||||||
Oxamflatin | 151720-43-3 | sc-205960 sc-205960A | 1 mg 5 mg | $151.00 $470.00 | 4 | |
Oxamflatin is an HDAC inhibitor that could potentially modulate histone acetylation and influence gene expression. | ||||||
Scriptaid | 287383-59-9 | sc-202807 sc-202807A | 1 mg 5 mg | $64.00 $183.00 | 11 | |
Scriptaid is an HDAC inhibitor that could lead to increased acetylation of histones, potentially affecting their expression. | ||||||
N-Methyl-N-propargylbenzylamine | 555-57-7 | sc-236062 | 5 g | $68.00 | ||
Pargyline is a monoamine oxidase inhibitor that has also been shown to affect histone modifications, potentially influencing gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine is a DNA methyltransferase inhibitor and could induce hypomethylation of histone genes, leading to their increased expression. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide has been reported to affect NF-κB pathway, which indirectly could influence histone modification and gene expression. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Anacardic acid is a natural compound that inhibits HATs and could alter histone acetylation, potentially affecting expression. | ||||||
Apicidin | 183506-66-3 | sc-202061 sc-202061A | 1 mg 5 mg | $110.00 $343.00 | 9 | |
Apicidin is a cyclic tetrapeptide HDAC inhibitor that could affect histone acetylation levels and gene expression. | ||||||